AI and sedation study aims to improve sleep apnea diagnosis
NCT ID NCT07459322
Summary
This study compares two sedation drugs (remimazolam and dexmedetomidine) used during a sleep apnea diagnostic test called DISE. Researchers want to see which drug provides better sedation with fewer side effects and faster recovery. They will also use artificial intelligence to analyze sleep study data to help doctors better identify where airway blockages occur.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fu Jen Catholic University Hosptial
New Taipei City, Taiwan (r.o.c.), 24352, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.